AboutContactTerms & Privacy
© 2024 Coverager
All Rights Reserved

Hyku

Biotech company that develops precise covalent targeting of disease-causing proteins.

Headquarters
Lexington, Massachusetts, United States
Founded
2021
Operating Status
Active
Ownership Type
Links
Number of funding rounds 1
Number of investors 6
Total funding amount $56M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.